ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,712.20
-1.12%
US Tech 100
19,375.20
0.00%
다우존스 지수
42,454.79
-0.31%
Bitcoin
87,360.05
0.54%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Pliant Therapeutics Inc (PLRX)

  7. Pliant Therapeutics Inc (PLRX) 뉴스

PLRX

Pliant Therapeutics (PLRX)

Pliant Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:PLRX
일자시간출처헤드라인심볼기업
2025/03/1721:00GlobeNewswire Inc.Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid TumorsNASDAQ:PLRXPliant Therapeutics Inc
2025/03/1321:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
2025/03/1321:05Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NASDAQ:PLRXPliant Therapeutics Inc
2025/03/1320:20GlobeNewswire Inc.Pliant Therapeutics Adopts Limited Duration Stockholder Rights AgreementNASDAQ:PLRXPliant Therapeutics Inc
2025/03/0406:18Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PLRXPliant Therapeutics Inc
2025/03/0406:10Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PLRXPliant Therapeutics Inc
2025/03/0406:05GlobeNewswire Inc.Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial ResultsNASDAQ:PLRXPliant Therapeutics Inc
2025/03/0323:27GlobeNewswire Inc.Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary FibrosisNASDAQ:PLRXPliant Therapeutics Inc
2025/02/1323:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
2025/02/1322:00GlobeNewswire Inc.Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary FibrosisNASDAQ:PLRXPliant Therapeutics Inc
2025/02/1021:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
2025/02/0806:58GlobeNewswire Inc.Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary FibrosisNASDAQ:PLRXPliant Therapeutics Inc
2025/01/2808:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
2025/01/2808:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
2025/01/2808:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
2025/01/2807:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
2025/01/2308:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
2025/01/2308:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
2025/01/2307:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
2025/01/2307:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
2025/01/2306:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PLRXPliant Therapeutics Inc
2025/01/2306:00GlobeNewswire Inc.Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PLRXPliant Therapeutics Inc
2025/01/2222:00GlobeNewswire Inc.Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical OfficerNASDAQ:PLRXPliant Therapeutics Inc
2025/01/0222:00GlobeNewswire Inc.Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PLRXPliant Therapeutics Inc
2024/11/2122:00GlobeNewswire Inc.Pliant Therapeutics to Participate in Upcoming Investor EventsNASDAQ:PLRXPliant Therapeutics Inc
2024/11/1908:00GlobeNewswire Inc.Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024NASDAQ:PLRXPliant Therapeutics Inc
2024/11/1507:05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PLRXPliant Therapeutics Inc
2024/11/0806:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLRXPliant Therapeutics Inc
2024/11/0806:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
2024/11/0806:05GlobeNewswire Inc.Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:PLRXPliant Therapeutics Inc
 검색 관련기사 보기:NASDAQ:PLRX

최근 히스토리

CSE
SI
Silicon Metals
AMEX
KRE
SPDR S&P Regional Banking
AMEX
EQAL
Invesco Russell 1000 Equ...
USOTC
ASPR
Adsouth Partners (PK)
TG
IMU
Immunogen Inc Dl 01
COIN
SIBUSD
SIBCoin
COIN
QXEUSD
Quixxi Connect Coin
ASX
HLI
Helia
LSE
NCCL
Ncondezi Energy
DOWI
DJIP2
DJ Islamic Market AsiaPa...
USOTC
FUCIF
First Trust Global Funds... (GM)
BIT
SG
SAES Getters
TG
HCL
Hecla Mining
LSE
VCT
Victrex
TSX
XCH
iShares China Index ETF
COIN
SPABTC
Delayed Upgrade Clock
ADVFN Logo
대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지